Digital health technologies in clinical trials can make it possible to collect meaningful data from participants outside the traditional research site. Wearables, mobile applications, connected sensors, electronic outcome assessments, and other tools can capture information where participants actually live, work, sleep, and move through their daily routines. That can make participation more convenient while creating opportunities for more frequent or continuous data collection. But introducing a device into a protocol does not automatically create a successful digital trial experience. The technology has to work for the study, the participant has to understand how to use it, and support has to be available when something does not go as planned.

Digital Health Extends the Trial Beyond the Research Site

Digital health technologies can collect measures such as activity, sleep, vital signs, biomarkers, performance outcomes, and patient-reported information remotely. Unlike data captured only during periodic site visits, some technologies can collect information more frequently or continuously, potentially providing a broader view of how a participant feels or functions in everyday life.

This is part of what makes digital health technologies in clinical trials so valuable. Remote data collection can support decentralized elements and reduce the need for some activities to occur at a traditional research site. It may also make participation more practical for people who live farther from research centers or face mobility, work, caregiving, or other barriers to frequent travel.

But moving an activity away from the site also changes where some of the operational responsibility sits. When a participant is asked to charge a wearable, sync data, respond to an app notification, complete an assessment, or troubleshoot connectivity from home, tasks once supported directly by site staff become part of the participant experience.

That makes the support model just as important as the device.

A Fit-for-Purpose Device Still Has to Be Usable

A digital health technology should be fit for the specific purpose it serves in the trial. That means considering whether it measures the intended clinical characteristic appropriately, whether its performance has been sufficiently verified and validated, and whether it is suitable for the population expected to use it.

Usability is part of that equation.

Age, language, physical condition, education, and comfort with technology can all affect how participants interact with a digital tool. Screen size, text, buttons, battery life, device weight, connectivity requirements, and the complexity of the user interface can influence whether a participant can use a technology consistently throughout a study.

A technically sophisticated device can still create friction if the participant does not understand when to wear it, how to sync it, what an alert means, or what to do when it stops transmitting.

This is why selecting a device should not be separated from planning the participant experience around it.

Training Is Part of the Data Strategy

Participant training should begin before digital data collection begins, but effective training needs to go beyond handing someone an instruction sheet.

Participants may need guidance on setting up and activating a device, wearing or using it correctly, collecting data at the right times, connecting to wireless networks, uploading or syncing information, responding to alerts, and handling software or hardware updates. Training may also need to be refreshed when the technology changes or when participants experience difficulty during the study.

The goal is not simply to teach someone where to press a button. Participants should understand what is expected of them and feel comfortable asking for help when something is unclear.

Caregivers may also need training in studies where they help participants interact with the technology. For some populations, that support can be particularly important when physical limitations, cognitive challenges, age, or disease symptoms make independent device use more difficult.

Good training helps turn technology from an additional trial requirement into something a participant can realistically incorporate into daily life.

Reminders and Follow-Up Can Protect Data Completeness

Remote collection creates convenience, but it can also create new opportunities for missing data.

A participant may forget to charge a device. An assessment may go unfinished. A sensor may be worn incorrectly. Data may stop syncing without the participant realizing it. Connectivity may fail. An alert may appear and be ignored because its meaning is unclear.

Planning for those situations matters because the way a DHT is used can affect both the amount and type of missing data in a study. Strategies such as automated monitoring, participant reminders, run-in periods, alerts, and proactive outreach can be used to reduce missing data and identify problems before they persist.

The value of that engagement is also visible in real-world digital research. A 12-month decentralized study involving 298 participants used structured participant engagement and technology support alongside smartwatch data collection. Ninety-two percent of enrolled participants completed the study, and average smartwatch wear-time adherence was 77.4 percent over the 12-month period. The results demonstrate that sustained digital participation is feasible when technology use is supported by an engagement strategy rather than treated as a passive activity.

Reminders work best when they are part of a broader workflow. When repeated missed data or unsuccessful digital outreach occurs, there should be a clear path to human follow-up.

Troubleshooting Needs a Human Workflow

Technical problems are inevitable in long-running studies.

Devices can be lost or damaged. Batteries fail. Software gets updated. Wireless connections drop. Mobile operating systems change. Participants may enter passwords incorrectly or simply become frustrated.

A study using digital health technologies should therefore have a defined technical assistance plan and procedures for responding to device malfunction, connectivity failures, lost equipment, software changes, and other problems that could interrupt data collection. Contingency plans may also be needed when a device cannot immediately be replaced or restored.

Just as importantly, participants need to know whom to contact.

The difference between a brief technical issue and several days of missing data may come down to whether the participant can quickly reach someone who understands both the technology and the study workflow.

Support pathways can include digital notifications, SMS, email, call center outreach, site escalation, or live assistance depending on the protocol and participant population. Serva Health’s own clinical technology model similarly combines mobile communications, reminders, live outreach, patient tracking, and call center capabilities within the broader patient engagement workflow, illustrating how digital tools and human support can operate together rather than as separate systems.

Technology Should Reduce Burden, Not Relocate It

Digital health technologies in clinical trials have the potential to make research more flexible and more connected to participants’ real lives. But convenience cannot be measured only by the number of site visits removed.

If a participant replaces travel time with confusing setup procedures, repeated troubleshooting, difficult interfaces, or unanswered questions, burden has not necessarily disappeared. It may simply have moved from the research site to the participant’s home.

That is why successful digital implementation requires more than choosing the right device. It requires planning the entire support environment around it: usability, training, reminders, monitoring, troubleshooting, communication, escalation, and access to human help.

The future of digital clinical research is not technology replacing patient support. It is technology making new forms of participation possible while patient support helps make those technologies workable in the real world.